Molecular Profiling Leads to Non-Standard Pancreatic Cancer Treatments
With stage IV pancreatic cancer, Rick Baker realized he needed to try many different treatments, including clinical trials.
With stage IV pancreatic cancer, Rick Baker realized he needed to try many different treatments, including clinical trials.
A clinical trial tests a signal-inhibiting drug for lung cancers with specific genetic mutations on gastrointestinal cancers with the same tumor mutations.